Back to results
US 2014/0350062 A1Published application
Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration
AssigneeSK Biopharmaceuticals Co., Ltd.
InventorsCheol Hyoung PARK, Hye Kyung MIN, In Suk PARK, Mi Jung LIM, Ji Won LEE, Jin Yong CHUNG, Yeo Jin YOON, Joo Young PARK
Life of this patent
Estimating the term…
Abstract
Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.
Claims4
1-9. (canceled)
A method for prevention or treatment of a neurodegenerative disease, comprising:
- administering to a subject in need of such prevention or treatment a therapeutically effective amount of a compound of Formula I, a pharmaceutically acceptable salt, an isomer, a solvate, or a hydrate thereof, or any combination thereof:
- wherein R is selected from the group consisting of substituted or unsubstituted C1-C15 arylalkyl, substituted or unsubstituted C1-C15 heteroarylalkyl, and substituted or unsubstituted, linear, branched or cyclic C1-C10 alkyl;
- Y is selected from the group consisting of 0 and —N—R1;
- R1 is at least one selected from the group consisting of —H and linear or branched C1-C3 alkyl;
- R2 is selected from the group consisting of —H and halo;
- A is selected from the group consisting of N, O, and S;
- B is C or N;
- Z is selected from the group consisting of carbamate, —OC(═O)NR3R4, —NH2, —NR5R6, —NC(═NH)NH2, and —NC(═O)NH2;
- each of R3 and R4 is independently selected from the group consisting of C1-C5 alkyl substituted with at least one selected from the group consisting of —H, —NH2 and —NR7R8, unsubstituted C1-C5 alkyl, heterocyclic group substituted with C1-C3 alkyl, and unsubstituted heterocyclic group, or R3 and R4 are taken together to form a 5- or 7-membered heterocyclic group substituted with C1-C5 alkyl or unsubstituted 5- to 7-membered heterocyclic group;
- each of R5 and R6 is independently selected from the group consisting of —H, C2-C3 alkenyl, C2-C3 alkynyl, and linear or branched C1-C7 alkyl unsubstituted or substituted with at least one selected from the group consisting of —OH, —C(O)NH2, C1-C3 alkoxy and carbamate, or R5 and R6 are taken together to form substituted or unsubstituted aliphatic cyclic amine or substituted or unsubstituted aromatic cyclic amine;
- each of R7 and R8 is independently at least one selected from the group consisting of —H and linear or branched C1-C3 alkyl;
- m is an integer in the range of 0 to 4;
- and
- n is an integer in the range of 0 to 5.
11 more elements
Dependencies are inferred from the claim text.